<?xml version="1.0" encoding="UTF-8"?>
<ref id="B68-vaccines-08-00531">
 <label>68.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mazloum</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Zhukov</surname>
    <given-names>I.U.</given-names>
   </name>
   <name>
    <surname>Aronova</surname>
    <given-names>E.B.</given-names>
   </name>
   <name>
    <surname>Igolkin</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Vlasova</surname>
    <given-names>N.N.</given-names>
   </name>
  </person-group>
  <article-title>ASF virus replication features in the presence of recombinant proteins CD2v, pX69R and pE248R</article-title>
  <source>Vopr. Virusol.</source>
  <year>2019</year>
  <volume>64</volume>
  <fpage>193</fpage>
  <lpage>200</lpage>
  <pub-id pub-id-type="doi">10.36233/0507-4088-2019-64-4-193-200</pub-id>
  <?supplied-pmid 32163686?>
  <pub-id pub-id-type="pmid">32163686</pub-id>
 </element-citation>
</ref>
